Medtronic's next-gen heart implants clear EU regulatory hurdle

02/5/2013 | MassDevice.com (Boston)

European regulators have granted Medtronic CE mark approval to market a next-generation line of its Evera implantable cardioverter defibrillators. The newly approved product line comes with a more contoured and thinner design for improved fit within the body and as much as 11 years of battery life, according to the company.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL